BOUL: Margins improved and cost savings realized, with OEM growth and new U.S. distribution boosting outlook

About this update from Boule Diagnostics Ab

Q4 saw stable performance with improved margins and significant cost savings from restructuring, despite a slight sales decline due to pricing and the India license model. OEM growth was strong, and a new U.S. distribution deal is set to boost future revenue.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Boule Diagnostics Ab